Related Experiment Video
Updated: Jul 3, 2026
09:39
A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
Pharmacy-based laboratory services: past or future and risk or opportunity?
Giuseppe Lippi1, Gérard Siest, Mario Plebani
1Sezione di Chimica Clinica, Dipartimento di Scienze Morfologico-Biomediche, Università degli Studi di Verona, Verona, Italy. ulippi@tin.it
Clinical Chemistry and Laboratory Medicine
|July 9, 2008
Summary
Decentralized laboratory diagnostics offer new opportunities but require quality standards. Pharmacies can leverage their historical expertise and education to provide effective on-site testing services.
Area of Science:
- Clinical diagnostics
- Laboratory medicine
- Pharmaceutical sciences
Background:
- Laboratory diagnostics are evolving with new technologies and organizational models.
- Decentralization allows for on-site and mobile testing outside traditional clinical labs, such as in pharmacies.
- This shift presents both opportunities and risks for diagnostic accuracy and clinical utility.
Purpose of the Study:
- To explore the potential for pharmacies to conduct on-site laboratory testing.
- To emphasize the necessity of fulfilling competency, quality, and consultancy prerequisites for decentralized testing.
- To assess the suitability of pharmacy education for expanding diagnostic roles.
Main Methods:
- Review of current trends in laboratory diagnostics and decentralization.
- Analysis of the historical role of pharmacies in clinical chemistry.
- Examination of European pharmacy syllabi for relevant knowledge domains.
Main Results:
- Compact and reliable instruments enable testing in non-traditional settings like pharmacies.
- Successful on-site testing requires adherence to stringent quality and competency standards.
- Pharmacy education provides a foundation in physiopathology suitable for diagnostic services.
Conclusions:
- On-site laboratory testing in pharmacies is feasible and can enhance healthcare access.
- Ensuring a core set of prerequisites is crucial for the efficiency and efficacy of decentralized testing.
- Pharmacy graduates possess the necessary knowledge base to support the evolution towards expanded diagnostic roles.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...